A similar analysis confined to dedifferentiated chondrosarcomas unveiled a significant difference in five-year OS between IDH mutant and IDH WT patients with IDH WT patients displaying a higher survival proportion at the final endpoint (p = 0.0434). This evidence concerns the gene IDH2 and chondrosarcoma.